Evidence map›Paper›PMID 42653795›Full record

ArticlePharmaceuticals (Basel, Switzerland)2026

D/PVA/I-1 as an Antibiotic Adjuvant: In Vitro Synergy and Membrane Permeabilization in MDR Bacteria.

Ardak Jumagaziyeva, Seitzhan Turganbay, Anar Seisembekova, Daniil Shepilov, Zhanar Iskakbayeva, Sabina Kenesheva, Saltanat Jumabayeva, Gaukhar Askhatkyzy, Nurdaulet Temir, Abdurashit Khamidulin and 1 more

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ardak JumagaziyevaScientific Center for Anti-Infectious Drugs JSC, Almaty 050060, Kazakhstan.ORCID 0000-0002-8610-7321
Seitzhan TurganbayFaculty of Natural Sciences, Kazakh National Women's Teacher Training University, Almaty 050000, Kazakhstan.ORCID 0000-0001-9621-3534
Anar SeisembekovaScientific Center for Anti-Infectious Drugs JSC, Almaty 050060, Kazakhstan.ORCID 0000-0002-7791-3145
Daniil ShepilovScientific Center for Anti-Infectious Drugs JSC, Almaty 050060, Kazakhstan.ORCID 0009-0003-0471-0587
Zhanar IskakbayevaScientific Center for Anti-Infectious Drugs JSC, Almaty 050060, Kazakhstan.ORCID 0000-0001-7428-0074
Sabina KeneshevaScientific Center for Anti-Infectious Drugs JSC, Almaty 050060, Kazakhstan.ORCID 0000-0001-9154-1424
Saltanat JumabayevaScientific Center for Anti-Infectious Drugs JSC, Almaty 050060, Kazakhstan.
Gaukhar AskhatkyzyScientific Center for Anti-Infectious Drugs JSC, Almaty 050060, Kazakhstan.
Nurdaulet TemirScientific Center for Anti-Infectious Drugs JSC, Almaty 050060, Kazakhstan.ORCID 0009-0008-8533-3029
Abdurashit KhamidulinScientific Center for Anti-Infectious Drugs JSC, Almaty 050060, Kazakhstan.ORCID 0009-0002-3163-5730
Alexandr IlinScientific Center for Anti-Infectious Drugs JSC, Almaty 050060, Kazakhstan.

Funding

Committee of Science of the Ministry of Science and Higher Education of the Republic of Kazakhstan Grant No. BR24992760
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antibiotic potentiationantimicrobial resistanceD/PVA/I-1ESKAPE pathogensFICIMDRmembrane permeabilitymultidrug-resistant bacteriasynergismtime-kill assay

Identifiers

PMID42653795
PMCPMC13516545

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.